ADMA vs JLL · P/E 22, rev $238.9M vs P/E 23, rev $13.31B
ADMA Biologics Inc (ADMA) versus Jones Lang LaSalle Incorporated (JLL) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Jones Lang LaSalle Incorporated (JLL) is a real estate services company listed on US.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported JLL revenue for 2026-06-30 was $13.31B. Net income was $373.7M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
Not investment advice. Open the ADMA and JLL stock pages for the full models.
Not investment advice.